Robert W Baird
-
Baird Boosts Price Target on Genentech (DNA), Sees Takeover Between $100-$110
-
Pre-Open Movers 7/21: Genentech (DNA) Higher on Bid for Roche; BofA (BAC) Up on Results
-
Baird Boosts Price Target on Genetch (DNA) to $95, Sees Higher Bid for Roche
-
Baird Reiterates Outperform on Genentech (DNA)
